| Literature DB >> 6359576 |
D B Rylatt, A S Blake, L E Cottis, D A Massingham, W A Fletcher, P P Masci, A N Whitaker, M Elms, I Bunce, A J Webber.
Abstract
Monoclonal antibodies (MAb) were raised against human D dimer. The hybridomas were screened with a solid phase enzyme immunoassay against D dimer and fibrinogen degradation products. Among the panel of MAb identified, two distinct patterns emerged; the majority belonging to a panspecific class reacting against epitopes present on both D dimer and fibrinogen degradation product Dcate and a monospecific class reacting with determinants apparently present only on D dimer. A number of MAb were further characterised for their ability to specifically capture antigen in a solid phase enzyme immunoassay and assays were developed which have a sensitivity of 10 ng/ml for D dimer or crosslinked fibrin derivatives and may be suitable for detection of crosslinked derivatives in serum and plasma samples in a clinical situation.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6359576 DOI: 10.1016/0049-3848(83)90108-1
Source DB: PubMed Journal: Thromb Res ISSN: 0049-3848 Impact factor: 3.944